Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

For a long time, the holy grail of Parkinson's development [has been] to really focus on a cure or some kind of disease-modifying therapy,” explained Case. “However, there are a lot of challenges in ...

Just three days after a performance at Carnegie Hall, Hathaway was cast in her first TV role on Get Real, a short-lived teen ...

Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...

Academy Award winning actor Anne Hathaway is celebrating her 42nd birthday today and on the occasion, we have a list of her ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...